Sharing innovation to inspire action

Vaccine delivers 94% drop in symptomatic COVID-19 cases

post-image

“Israel’s largest healthcare provider...reported a 94% drop in symptomatic COVID-19 infections among 600,000 people who received two doses of the Pfizer’s vaccine in the country’s biggest study to date.

...HMO Clalit, which covers more than half of all Israelis, said the same group was also 92% less likely to develop severe illness from the virus.

The comparison was against a group of the same size, with matching medical histories, who had not received the vaccine.”

 https://www.reuters.com/article/us-health-coronavirus-israel-vaccine-idUSKBN2AE0Q2

What do you think?

You must be logged in to post a comment.
Comments
Lynn Wood @ 2021.02.15 5:28 AM
Another reason this vaccine is so special https://www.ideaspies.com/posts/genetic-coding-to-become-as-important-as-digital-coding

Generic placeholder image

By Maria MacNamara

15 February 2021

 
6 Like


Related Posts

COVID-19

post-image

Israeli researchers say spirulina algae could reduce COVID mortality rate
25 February 2021 by Jeremy Ungar 0 Comments
 
6 Like

COVID-19

post-image

Innovating training environments is the new normal
10 February 2021 by Louise Nealon... 0 Comments
 
4 Like

COVID-19

post-image

E-learning Becomes Imperative Not a Choice
5 February 2021 by Jeremy Ungar 0 Comments
 
8 Like